Biopure Corporation Receives Notice of Delisting from Nasdaq

Dow Jones

39,331.85

Get Started

Share Name	Share Symbol	Market	Type
Biopure (MM)	NASDAQ:BPUR	NASDAQ	Common Stock

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	0.00	0.00%	0.075						0	01:00:00

Biopure Corporation Receives Notice of Delisting from Nasdaq

17/07/2009 8:30pm

PR Newswire (US)

Biopure (MM) (NASDAQ:BPUR)
Historical Stock Chart

From Jul 2019 to Jul 2024

Click Here for more Biopure (MM) Charts.

CAMBRIDGE, Mass., July 17 /PRNewswire-FirstCall/ -- Biopure Corporation (NASDAQ:BPUR) announced that it has received notice from The Nasdaq Stock Market, by letter dated July 17, 2009, that its common stock would be delisted from Nasdaq. The notice stated that because of concerns raised by the Company's filing for protection under Chapter 11 of the Bankruptcy Code, trading would be suspended at the opening of business on July 28, 2009. The company does not intend to appeal this decision. Biopure Corporation Biopure Corporation develops and markets pharmaceuticals, called oxygen therapeutics, that are intravenously administered to deliver oxygen to the body's tissues. Contact: Zaf Zafirelis Biopure Corporation (617) 234-6500 DATASOURCE: Biopure Corporation CONTACT: Zaf Zafirelis of Biopure Corporation, +1-617-234-6500, Web Site: http://www.biopure.com/